Warning: I'm on a soapbox here, spurred by the
contents of a weekly healthnews alert:

Background:  While I am all for increased consumer
(new term for what used to be called "a patient")
awareness, without increased _education_ about various
conditions, 'awareness' tends to promote fear and a
rush for the latest "fixitol" drug -- which may be no
better than older drugs in the same class or even
older drugs from other classes.  Not to mention the
fact that _prevention_ of the condition might be
non-drug related things like proper nutrition,
exercise, smoking cessation etc.  Which of course
takes commitment on the part of the 'consumer,' and
might profit diet and exercise gurus instead of Merck,
Roche or other drug manufacturers.

Anyone who's watched TV in the US in the past couple
of months should be able to answer "what's that purple
pill for?" (Nexium, for regular heartburn/gastric
distress)  Now while it does an admirable job of
controlling stomach acid secretion, is it any better
*in a clinically relevant* sense than its older
siblings?  No.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12872509&dopt=Abstract

Generic omeprazole (Prilosec) at this site is $76 for
a 28-day supply; the brand name variety is $116.
http://www.medicapharma.com/Antacids/antacids.html?source=look
A 30-day supply of Nexium is $202 at this site
http://www.valueprescribe.com/nexium/?AffiliateID=2003049723
or over twice the generic omeprazole -- which hasn't
been shown to be inferior to the 'newbie.'  [Note that
there _are_ cases where a brand name matters - frex
generic digoxin seems to be much harder to keep at
stable levels than Lanoxin, in my and many
cardiologists' experience; _bioavailability_ can vary
dramatically in different delivery vehicles (frex pill
ingredient composition which may include "inert
carriers", pill structure etc.).]

Now developing a new drug is _costly_, and most 
chemicals tested fail somewhere along the line from
invention or discovery to 'safe and effective
medication;' a pharmaceutical company must make a
profit to be able to develop new drugs and pay the
bills etc.  But drugs in many categories are *not*
new, and might even be a metabolite or similar
derivative of the 'old' drug, or simply in a different
delivery vehicle (chewable, frex).  The development
cost of such a drug is far less than a de novo one.
This Frontline program has a great deal of information
for those interested in the costs of medication:
http://www.pbs.org/wgbh/pages/frontline/shows/other/etc/synopsis.html

Marketing ploys in direct-to-consumer ads include
tactics that have *no* clinical relevance, such as
"Our statin (cholesterol-lowering drug) does at 20mg
per dose what Brand X does at 80mg!"  If the price,
side-effects and clinical outcomes are similar, that
is *completely* irrelevant.  Another: "Brand Y isn't
approved for this particular application" -- but the
final pathway for the condition is identical
-histamine blockage, frex, so testing an antihistamine
for its control of dog allergies vs. cat allergies is
moot.

What brought this up today is the recent
release/approval of Levitra, new competitor for
Viagra:
http://www.msnbc.com/news/954753.asp
"...There have been no published studies directly
comparing the pills to determine advantages of each.
But the potency, speed and duration of each drug are
hotly disputed..."

In the same newsletter are articles on how those who
exercise have lower risk of impotence, how bad
lifestyle choices increase the risk of heart disease,
and how angioplasty (a procedure to open up coronary
arteries without massive surgery - unless
complications require emergent intervention) is better
than 'clot-buster' drugs for those having a heart
attack, at least in one Danish study:
http://www.msnbc.com/news/953944.asp
http://www.msnbc.com/news/954499.asp
http://www.msnbc.com/news/955040.asp

I've previously read about most of the above
information in various medical updates I get, but
having them all show in the same issue of one
'healthblurbs' subscription just seemed...infuriating.

"...and all for the want of a horseshoe nail!"

Debbi
who is crabby with a headcold today, and so highly
intolerant of deliberate ignorance  :P

__________________________________
Do you Yahoo!?
Yahoo! SiteBuilder - Free, easy-to-use web site design software
http://sitebuilder.yahoo.com
_______________________________________________
http://www.mccmedia.com/mailman/listinfo/brin-l

Reply via email to